---
title: "Dupixent (dupilumab) in atopic dermatitis: Guidelines questions"
description: "Guidelines questions on Dupixent (dupilumab) in atopic dermatitis, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Questions: Is Dupixent recommended in atopic dermatitis treatment guidelines? 1 question quoted from 1 source."
canonical: "https://www.evicenter.com/medical-information/dupixent--atopic-dermatitis/guidelines"
published: "2026-11-12T22:05:36-05:00"
modified: "2026-11-14T15:19:23-05:00"
---

# Dupixent (dupilumab) in atopic dermatitis: Guidelines questions

Manufacturer: sanofi-aventis U.S. LLC; Regeneron Pharmaceuticals, Inc.  
Prescribing information: [Dupixent](https://www.regeneron.com/downloads/dupixent_fpi.pdf)

## Guidelines

<a id="dupixent-ad-guidelines"></a>

### Is Dupixent recommended in atopic dermatitis treatment guidelines?

> “Strong recommendation for the use of DUPIXENT in AAD and AAAAI/ACAAI Joint Task Force AD Guidelines<sup>2,3,f</sup>”

Source: [DUPIXENT: DUPIXENT® (dupilumab) for Moderate-to-Severe Atopic Dermatitis That is Uncontrolled, captured 2026-11-12](https://www.dupixenthcp.com/atopicdermatitis/#:~:text=Strong%20recommendation%20for%20the%20use,AAAAI%2FACAAI%20Joint%20Task%20Force%20AD)

> “Inclusion in AAD and AAAAI/ACAAI AD Guidelines does not denote endorsement or recommendation of product use by AAD and AAAAI/ACAAI.”

Source: [DUPIXENT: DUPIXENT® (dupilumab) for Moderate-to-Severe Atopic Dermatitis That is Uncontrolled, captured 2026-11-12](https://www.dupixenthcp.com/atopicdermatitis/#:~:text=Inclusion%20in%20AAD%20and%20AAAAI%2FACAAI,use%20by%20AAD%20and%20AAAAI%2FACAAI.)

## Related pages
- [Medical information: Dupixent (dupilumab): Atopic dermatitis](https://www.evicenter.com/medical-information/dupixent--atopic-dermatitis)
- [Indication](https://www.evicenter.com/medical-information/dupixent--atopic-dermatitis/indication)
- [Pharmacology](https://www.evicenter.com/medical-information/dupixent--atopic-dermatitis/pharmacology)
- [Clinical trials](https://www.evicenter.com/medical-information/dupixent--atopic-dermatitis/clinical-trials)
- [Real-world evidence](https://www.evicenter.com/medical-information/dupixent--atopic-dermatitis/real-world-evidence)
- [Safety](https://www.evicenter.com/medical-information/dupixent--atopic-dermatitis/safety)
- [Specific populations](https://www.evicenter.com/medical-information/dupixent--atopic-dermatitis/specific-populations)
- [Drug interactions](https://www.evicenter.com/medical-information/dupixent--atopic-dermatitis/drug-interactions)
- [Dosing and administration](https://www.evicenter.com/medical-information/dupixent--atopic-dermatitis/dosing-and-administration)
- [Storage and supply](https://www.evicenter.com/medical-information/dupixent--atopic-dermatitis/storage-and-supply)
- [Access and coverage](https://www.evicenter.com/medical-information/dupixent--atopic-dermatitis/access-and-coverage)
